Brighton Jones’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$416K Sell
74,372
-260
-0.3% -$1.63K 0.01% 895
2026
Q2
$424K Buy
74,632
+600
+0.8% +$2.93K 0.01% 870
2026
Q1
$318K Buy
+74,032
New +$412K 0.01% 907
2025
Q4
– Sell
-73,163
Closed -$271K – 653
2025
Q3
$271K Buy
73,163
+11,502
+19% +$31.3K 0.01% 848
2025
Q2
$120K Buy
+61,661
New +$128K ﹤0.01% 887

Other funds holding NUVB

Brighton Jones's NUVB Position: Q3 2026 in Review

Brighton Jones reduced its Nuvation Bio (NUVB) stake by 0.35% in Q3 2026, selling an estimated $1.63K and leaving 74,372 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #895.

Brighton Jones first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $424K in Q2 2026. 231 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Brighton Jones held 74,372 shares of Nuvation Bio worth $416K as of Q3 2026.
  • Brighton Jones sold 260 Nuvation Bio shares in Q3 2026, an estimated $1.63K.
  • Nuvation Bio made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #895 holding.
  • Brighton Jones first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Brighton Jones's Nuvation Bio position peaked at $424K in Q2 2026.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.